Seeking Alpha

Valeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI...

Valeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI +0.2%) over its generic glumetza diabetes drug, according to reports. Sales of Glumetza are tipped to reach more than $100M this year.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)